SEC
Whistleblower
Advocates

January 17, 2017

Allergan, Inc.

Financial Fraud

SANCTION AMOUNT: $15,000,000

Defendants: Allergan, Inc.

Sanction based on Allergan's alleged failure to timely disclose negotiations with potentially friendlier merger partners in the months following a tender offer from Valeant Pharmaceuticals International and co-bidders in June 2014.

Thank you for submitting some email to us.